VaDDC
  • About
    • Join VaDDC
    • Affiliated Organizations
  • Leadership
    • Executive committee members
  • Events
    • VirginiaCancerRx
    • VirginiaBrainRx
    • VirginiaDrugDiscoveryRx-2018
    • VaDDRx: Emerging Targets, Technologies and Therapeutics for Cancer and Neuroscience -2019
  • News
  • Partnerships
    • Industry Initiatives
    • Featured Collaborations
    • Become a Sponsor
Select Page
Virginia Bio Names John Newby CEO

Virginia Bio Names John Newby CEO

by Discovery | Jul 31, 2019 | Uncategorized

Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...

Recent Posts

  • VaDDC Executive Committee Member, Beth Sharlow Receives Promotion at UVA
  • Virginia Company, Phlow Corp. Awarded $354 million to Produce Ingredients for Covid-19 Drugs
  • Virginia Bio Names John Newby CEO
  • Webster Santos – VT and Kevin Lynch-UVA received a $2.8 NIAID grant to Develop a Drug to Treat Multiple Sclerosis
  • NIH Provides $23 million for Statewide Translational Research Institute

Archives

  • June 2020
  • May 2020
  • July 2019
  • March 2019
  • December 2018
  • November 2018
  • September 2018
  • September 2017
  • June 2017
  • May 2017
  • February 2017
  • December 2016
  • November 2016
  • September 2016
  • July 2016
  • April 2015
  • Facebook
  • Twitter
  • RSS
© 2016 Virginia Drug Discovery Consortium